Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers

Neurology

Volumn 52, Issue 8, 1999, Pages 1610-1617

  Stewart, W F ^a   Schwartz, B S ^b   Simon, D ^a   Bolla, K I ^c   Todd, A C ^a   Links, J ^c  

^a Department of Epidemiology ^*  (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; ORGANOLEAD COMPOUND;

ADULT; AGED; ARTICLE; HUMAN; INTELLIGENCE; MALE; NEUROPSYCHOLOGY; OCCUPATIONAL EXPOSURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; TIBIA; TISSUE LEVEL; VERBAL MEMORY;

EID: 0033549098     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.8.1610     Document Type: Article

References (26)

1. Baker EL, White RF, Pothier LJ, et al. Occupational lead neurotoxicity: improvement in behavioral effects after reduction of exposure. Br J Ind Med 1985;42:507-516.
2. Balbus-Kornfeld JM, Stewart W, Bolla Kl, Schwartz BS. Cumulative exposure to inorganic lead and neurobehavioral test performance in adults: an epidemiologic review. Occup Environ Med 1995;52:2-12.
3. Haenninen H, Hemberg S, Manière P, et al. Psychological performance of subjects with low exposure to lead. J Occup Med 1978;20:683-689.
4. Harley JP, White R, Feldman R. Neuropsychological correlates of moderate lead exposure. Presented at the 10th annual meeting of the International Neuropsychological Society, 1982.
5. Lindgren KM, Masten VL, Ford DP, Bleecker ML. Relation of cumulative exposure to inorganic lead and neuropsychological test performance. Occup Environ Med 1996;53:472-477.
6. Bleecker ML, Lindgren KN, Ford DP. Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age. Neurology 1997;48:639645.
7. Osterberg K, Borjesson J, Gerhardsson L, Schutz A, Skerfving S. A neurobehavioral study of long-term occupational inorganic lead exposure. Sei Total Environ 1997;201:39-51.
8. Ryan CM, Morrow L, Parkinson D, Bromet E. Low level lead exposure and neuropsychological functioning in blue collar males. Int J Neurosci 1987;36:29-39.
9. Hu H, Milder FL, Burger DE. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. Environ Res 1989;49:295-317.
10. Schwartz BS, Stewart WF, Todd AC, Links JM. Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. Occup Environ Med 1999;56:22-29.
11. Lee B-K, Schwartz BS, Stewart W, Ahn K-D. Urinary lead excretion after DMSA and EDTA: evidence for differential access to lead storage sites. Occup Environ Med 1995;52:1319.
12. Schwartz BS, Lee B-K, Stewart W, Ahn K-D, Kelsey KT. S-Aminolevulinic acid dehydratase genotype modifies 4-hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 1997;54:241246.
13. Schwartz BS, Bolla KI, Stewart W, Ford DP, Agnew J, Frumkin H. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. Am J Epidemiol 1993;137:1006-1021.
14. Todd AC, McNeill FE. In vivo measurements of lead in bone using a Cd spot source. In: Ellis KJ, Eastman JD, eds. Human body composition studies. New York: Plenum Press, 1993: 299-302.
15. Durnin JVAG, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged 16 to 72 years. Br J Nutr 1974;32:77-97.
16. Kneip TJ, Crable JV. Methods for biological monitoring: a manual for assessing human exposure to hazardous substances. Washington, DC: American Public Health Associa- , tion, 1988:199-201.
17. Todd AC, McNeill FE, Palethorpe JE, et al. In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. Environ Res 1992b;57:117-132. /
18. Gerhardsson L, Attewell R, Chettle DR, et al. In vivo'measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health 1993;48:147-156.
19. McCullough P, Neider JA. Generalized linear models. London: Chapman & Hall, 1983.
20. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol 1995;40:14751485.
21. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-836.
22. Bolla KI, Schwartz BS, Stewart W, Rignani J, Agnew J, Ford
23. DP. A comparison of neurobehavioral function in workers exposed to a mixture of organic and inorganic lead and in workers exposed to solvents. Am J Ind Med 1995;27:231-246.
24. Michélsen H, Lundberg I. Neuropsychological verbal tests may lack "hold" properties in occupational studies of neurotoxic effects. Occup Environ Med 1996;53:478-483.
25. Stokes L, Letz R, Gerr F, et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med 1998;55:507-516.
26. Payton M, Riggs KM, Spiro A, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 1998;20:19-27.